1R. W. Keen,T. Nguyen,R. Sobnack,L. A. Perry,P. W. Thompson,Dr T. D. Spector. Can biochemical markers predict bone loss at the hip and spine?: A 4-year prospective study of 141 early postmenopausal women[J] 1996,Osteoporosis International(5):399～406
4Leidig Bruckner G,Ziegler R. Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes, 2001,109(suppl 2) :S493-S514.
5Oz SG,Guven GS, Kilicarslan A, et al. Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus. J Natl Med Assoc,2006, 98: 1598-1604.
6Dominguez LJ, Muratore M, Quarta E, et al. Osteoporosis and diabetes. Reumatismo, 2004,56: 235- 241.
7Thrailkill KM, Lumpkin CK Jr, Bunn RC, et al. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endoerinol Metab, 2005,289 : E735-745.
8Petrova NL, Foster AV, Edmonds ME, et al. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes. Diabet Med, 2005,22:756- 761.
9Akin O,Gol K , Erkava S. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol, 2003,17:19- 29.
10Komatsu Y, Majima T. Negative correlation between BMD and HbAlc in patients with type 2 diabetes. Clin Calcium, 2006,16 :1327 -1331.
